相似文献
1
Vaccination with Trypanosoma rangeli reduces the infectiousness of dogs experimentally infected with Trypanosoma cruzi.
Vaccine. 2007 May 10;25(19):3855-8. doi: 10.1016/j.vaccine.2007.01.114. Epub 2007 Mar 8.
2
Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
Immunobiology. 2015 Mar;220(3):428-36. doi: 10.1016/j.imbio.2014.10.003. Epub 2014 Oct 30.
3
Vaccination of dogs with Trypanosoma rangeli induces antibodies against Trypanosoma cruzi in a rural area of Córdoba, Argentina.
Mem Inst Oswaldo Cruz. 2016 Apr;111(4):271-4. doi: 10.1590/0074-02760160019.
4
Immune protection against Trypanosoma cruzi induced by TcVac4 in a canine model.
PLoS Negl Trop Dis. 2015 Apr 8;9(4):e0003625. doi: 10.1371/journal.pntd.0003625. eCollection 2015 Apr.
5
Preventive and therapeutic DNA vaccination partially protect dogs against an infectious challenge with Trypanosoma cruzi.
Vaccine. 2013 Apr 26;31(18):2246-52. doi: 10.1016/j.vaccine.2013.03.005. Epub 2013 Mar 13.
6
Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection.
Mem Inst Oswaldo Cruz. 2008 Jun;103(4):370-4. doi: 10.1590/s0074-02762008000400010.
7
Testing the efficacy of a multi-component DNA-prime/DNA-boost vaccine against Trypanosoma cruzi infection in dogs.
PLoS Negl Trop Dis. 2011;5(5):e1050. doi: 10.1371/journal.pntd.0001050. Epub 2011 May 17.
8
High levels of Trypanosoma cruzi DNA determined by qPCR and infectiousness to Triatoma infestans support dogs and cats are major sources of parasites for domestic transmission.
Infect Genet Evol. 2014 Jul;25:36-43. doi: 10.1016/j.meegid.2014.04.002. Epub 2014 Apr 13.
9
Vaccination with Trypanosoma rangeli induces resistance of guinea pigs to virulent Trypanosoma cruzi.
Vet Immunol Immunopathol. 2014 Jan 15;157(1-2):119-23. doi: 10.1016/j.vetimm.2013.10.011. Epub 2013 Oct 29.
10
Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
Vaccine. 2004 May 7;22(15-16):1868-72. doi: 10.1016/j.vaccine.2003.11.013.
引用本文的文献
1
Trypanosomatid Extracellular Vesicles as Potential Immunogens for Chagas Disease.
Int J Mol Sci. 2025 Feb 12;26(4):1544. doi: 10.3390/ijms26041544.
2
Chagas Disease: A Silent Threat for Dogs and Humans.
Int J Mol Sci. 2024 Mar 29;25(7):3840. doi: 10.3390/ijms25073840.
3
Investigation on Prevalence of Canine Trypanosomiasis in the Conservation Areas of Bwindi-Mgahinga and Queen Elizabeth in Western Uganda.
J Parasitol Res. 2022 Sep 10;2022:2606871. doi: 10.1155/2022/2606871. eCollection 2022.
4
Use of a small molecule integrin activator as a systemically administered vaccine adjuvant in controlling Chagas disease.
NPJ Vaccines. 2021 Sep 8;6(1):114. doi: 10.1038/s41541-021-00378-5.
5
The Case for the Development of a Chagas Disease Vaccine: Why? How? When?
Trop Med Infect Dis. 2021 Jan 26;6(1):16. doi: 10.3390/tropicalmed6010016.
6
Trypanosoma cruzi transmission dynamics in a synanthropic and domesticated host community.
PLoS Negl Trop Dis. 2019 Dec 13;13(12):e0007902. doi: 10.1371/journal.pntd.0007902. eCollection 2019 Dec.
7
Vaccination of dogs with Trypanosoma rangeli induces antibodies against Trypanosoma cruzi in a rural area of Córdoba, Argentina.
Mem Inst Oswaldo Cruz. 2016 Apr;111(4):271-4. doi: 10.1590/0074-02760160019.
8
Immune protection against Trypanosoma cruzi induced by TcVac4 in a canine model.
PLoS Negl Trop Dis. 2015 Apr 8;9(4):e0003625. doi: 10.1371/journal.pntd.0003625. eCollection 2015 Apr.
9
Heterogeneities in the ecoepidemiology of Trypanosoma cruzi infection in rural communities of the Argentinean Chaco.
Am J Trop Med Hyg. 2014 Jun;90(6):1063-73. doi: 10.4269/ajtmh.13-0251. Epub 2014 Apr 14.
10
Frequency of IFNγ-producing T cells correlates with seroreactivity and activated T cells during canine Trypanosoma cruzi infection.
Vet Res. 2014 Jan 23;45(1):6. doi: 10.1186/1297-9716-45-6.
本文引用的文献
1
Chagas disease control: deltamethrin-treated collars reduce Triatoma infestans feeding success on dogs.
Trans R Soc Trop Med Hyg. 2005 Jul;99(7):502-8. doi: 10.1016/j.trstmh.2004.11.013.
2
Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
Vaccine. 2004 May 7;22(15-16):1868-72. doi: 10.1016/j.vaccine.2003.11.013.
3
Action of Trypanosoma rangeli in infections with virulent Trypanosoma cruzi populations.
Mem Inst Oswaldo Cruz. 2003 Jun;98(4):543-8. doi: 10.1590/s0074-02762003000400022. Epub 2003 Aug 18.
4
Trypanosoma (Herpetosoma) rangeli Tejera, 1920: an updated review.
Mem Inst Oswaldo Cruz. 2003 Jun;98(4):435-42. doi: 10.1590/s0074-02762003000400001. Epub 2003 Aug 18.
5
Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection.
Infect Immun. 2002 Oct;70(10):5547-55. doi: 10.1128/IAI.70.10.5547-5555.2002.
6
Control of Chagas disease.
World Health Organ Tech Rep Ser. 2002;905:i-vi, 1-109, back cover.
7
DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection.
Infect Immun. 2001 Oct;69(10):6558-63. doi: 10.1128/IAI.69.10.6558-6563.2001.
8
Paraflagellar rod proteins administered with alum and IL-12 or recombinant adenovirus expressing IL-12 generates antigen-specific responses and protective immunity in mice against Trypanosoma cruzi.
Vaccine. 2000 Jan 31;18(14):1419-27. doi: 10.1016/s0264-410x(99)00380-1.
9
[Experimental Chagas' disease: I. Study of different immunization conditions in the infection course].
Bol Chil Parasitol. 1998 Jul-Dec;53(3-4):45-51.
10
The taxonomic position and evolutionary relationships of Trypanosoma rangeli.
Int J Parasitol. 1999 May;29(5):749-57. doi: 10.1016/s0020-7519(99)00016-8.
Zotero 插件